SlideShare ist ein Scribd-Unternehmen logo
1 von 1
Downloaden Sie, um offline zu lesen
Directly eliciting personal utility functions: a new
way to value health-related quality of life
(Poster PRM156)
Koonal Shah, Nancy Devlin (Office of Health Economics, UK)
Brendan Mulhern (CHERE, University of Technology Sydney, Australia)
Ben van Hout (ScHARR, University of Sheffield, UK)
For further information, contact kshah@ohe.org
BACKGROUND
• The end product of EQ-5D valuation studies is an algorithm describing, on average, the utility decrements associated
with each dimension and level of problems within the EQ-5D descriptive system
• Standard methods for eliciting health state preference data (e.g. TTO, DCE) vary considerably in approach, but have in
common an aim to ‘uncover’ these preferences by asking survey respondents to evaluate a sub-set of health states, and
then using their responses to infer the relative importance of the specific dimensions and levels to them
• An alternative (and novel) approach is to directly ask respondents about their own personal utility functions
• Instead of inferring respondents’ utility functions from their responses to abstract choice tasks, we propose directly
asking people about the relative importance of the health dimensions and levels, and the interactions between them
This study was funded by the EuroQol Research Foundation. The views expressed do not necessarily reflect the views of the EuroQol Research Foundation.
METHOD / KEY INNOVATIONS
• Paper- and computer-based tasks administered via F2F interviews
• Focus is on reflection and open discussion of responses
• Based on premise that respondents are constructing their preferences
• Some elements draw on swing weighting approach (MCDA literature)
A. WARM-UP TASKS
• Self-reported health using EQ-5D and EQ-VAS
• Ranking exercise: ranking of level-free
descriptions of the five EQ-5D dimensions
B. DIMENSION WEIGHTING TASK
• Five cards: each describes an improvement from extreme problems to no problems in one of the EQ-5D dimensions
• 0 to 100 scale: 100 refers to the most important improvement in health and 0 refers to an improvement that respondent
does not feel is important or valuable at all
• Respondent assigns a rating of 100 to the improvement (card) that is most important or valuable to them
• Respondent then rates the other improvements using the same scale and in relation to the most important improvement
• Responses generate a set of dimension weights, which will be presented diagrammatically to respondents (Fig 1)
C. LEVEL WEIGHTING TASK
• Three cards (for each dimension): no improvement (from extreme problems); intermediate improvement (from extreme
problems to moderate problems) and largest possible improvement (from extreme problems to no problems)
• 0 to 100 scale: 100 refers to the largest possible improvement and 0 refer to no improvement
• Respondent rates the intermediate improvement using the 0 to 100 scale
• Rating of 50 implies that respondent considers the improvement from extreme problems to moderate problems to be
about as important as the improvement from moderate problems to no problems – may not always be the case
• Responses generate a set of level weights, which will be combined with the dimension weights and presented
diagrammatically to respondents (Fig 2) – opportunity for respondents to reflect and amend their answers
D. VALIDATION EXERCISE
• The information collected in C and D will be validated using a series of pairwise choice tasks
• Purpose of the exercise is to validate our understanding of the responses and to identify any potential inconsistencies
E. POSITIONING OF DEAD
• Position of dead will be estimated by asking respondents to complete simple trade-off tasks where the unit of trade is
dimension-specific levels (as opposed to time or risk, as in TTO and standard gamble, respectively)
• Example: start with following pairwise choice: (X) 11113 for 10 years followed by death vs. (Y) ‘die immediately’
• If respondent prefers X, then X is worsened: (X) 31113 for 10 years followed by death vs. (Y) ‘die immediately’
• Continue until respondent switches to preferring Y, at which point the approximate location of dead can be identified
• Exact selection of health states presented in option X will follow directly from responses to dimension weighting task
Fig 1.
Output from B
Fig 2.
Output from B & C
Diagrams will be used to
check whether
respondents agree with
our interpretation of their
responses; changes to
earlier answers permitted
F. EXAMINATION OF INTERACTIONS
• Systematic approach will be used to examine interactions
G. DEBRIEFING
• Views about feasibility of the approach and suggestions for
improving questionnaire will be sought from both respondents
and interviewers
CURRENT STATUS
• Draft questionnaire has been developed
• Accompanying computer-based tool is in development
• Pilot interviews to be conducted in Q2 2015 using
convenience samples in Australia, Netherlands, UK
• Revised questionnaire will be tested in Q3/Q4 2015

Weitere ähnliche Inhalte

Was ist angesagt?

Nonparametric tests
Nonparametric testsNonparametric tests
Nonparametric tests
Arun Kumar
 
Parametric vs non parametric test
Parametric vs non parametric testParametric vs non parametric test
Parametric vs non parametric test
ar9530
 

Was ist angesagt? (20)

Item analysis
Item analysisItem analysis
Item analysis
 
Panel Data Models
Panel Data ModelsPanel Data Models
Panel Data Models
 
Difficulty Index, Discrimination Index, Reliability and Rasch Measurement Ana...
Difficulty Index, Discrimination Index, Reliability and Rasch Measurement Ana...Difficulty Index, Discrimination Index, Reliability and Rasch Measurement Ana...
Difficulty Index, Discrimination Index, Reliability and Rasch Measurement Ana...
 
EXAMINING DISTRACTORS AND EFFECTIVENESS
EXAMINING DISTRACTORS AND  EFFECTIVENESSEXAMINING DISTRACTORS AND  EFFECTIVENESS
EXAMINING DISTRACTORS AND EFFECTIVENESS
 
Assumptions about parametric and non parametric tests
Assumptions about parametric and non parametric testsAssumptions about parametric and non parametric tests
Assumptions about parametric and non parametric tests
 
Data Analysis
Data AnalysisData Analysis
Data Analysis
 
Nonparametric tests
Nonparametric testsNonparametric tests
Nonparametric tests
 
Non parametric-tests
Non parametric-testsNon parametric-tests
Non parametric-tests
 
QCI WORKSHOP- Factor analysis-
QCI WORKSHOP- Factor analysis-QCI WORKSHOP- Factor analysis-
QCI WORKSHOP- Factor analysis-
 
Instrumental Variables and Control Functions
Instrumental Variables and Control FunctionsInstrumental Variables and Control Functions
Instrumental Variables and Control Functions
 
Foundations of Experimental Design
Foundations of Experimental DesignFoundations of Experimental Design
Foundations of Experimental Design
 
Parametric vs non parametric test
Parametric vs non parametric testParametric vs non parametric test
Parametric vs non parametric test
 
One-Sample Hypothesis Tests
One-Sample Hypothesis TestsOne-Sample Hypothesis Tests
One-Sample Hypothesis Tests
 
Propensity Score Matching Methods
Propensity Score Matching MethodsPropensity Score Matching Methods
Propensity Score Matching Methods
 
Nonparametric hypothesis testing methods
Nonparametric hypothesis testing methodsNonparametric hypothesis testing methods
Nonparametric hypothesis testing methods
 
Amrita kumari
Amrita kumariAmrita kumari
Amrita kumari
 
Non parametric test
Non parametric testNon parametric test
Non parametric test
 
non parametric statistics
non parametric statisticsnon parametric statistics
non parametric statistics
 
Choosing the right statistics
Choosing the right statisticsChoosing the right statistics
Choosing the right statistics
 
Parametric tests
Parametric testsParametric tests
Parametric tests
 

Andere mochten auch

Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...
Office of Health Economics
 

Andere mochten auch (16)

Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
 
Devlin mcda philadelphia ispor 150515
Devlin  mcda philadelphia ispor 150515 Devlin  mcda philadelphia ispor 150515
Devlin mcda philadelphia ispor 150515
 
ISPOR poster ri lwcp 140515
ISPOR poster   ri lwcp  140515ISPOR poster   ri lwcp  140515
ISPOR poster ri lwcp 140515
 
A Comparison of Three EQ-5D Value sets
A Comparison of Three EQ-5D Value setsA Comparison of Three EQ-5D Value sets
A Comparison of Three EQ-5D Value sets
 
A New Approach to Presenting Health States in Stated Preference Valuation Stu...
A New Approach to Presenting Health States in Stated Preference Valuation Stu...A New Approach to Presenting Health States in Stated Preference Valuation Stu...
A New Approach to Presenting Health States in Stated Preference Valuation Stu...
 
Anchoring Vignettes: Identifying response bias and DIF in self assessed health
Anchoring Vignettes: Identifying response bias and DIF in self assessed healthAnchoring Vignettes: Identifying response bias and DIF in self assessed health
Anchoring Vignettes: Identifying response bias and DIF in self assessed health
 
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
Differential Pricing of Medicines in Europe:  Implications for Access, Innova...
 
OHE at PROMs Conference Sheffield 2016: Presentations and Posters
OHE at PROMs Conference Sheffield 2016: Presentations and PostersOHE at PROMs Conference Sheffield 2016: Presentations and Posters
OHE at PROMs Conference Sheffield 2016: Presentations and Posters
 
A new method for valuing quality of life: Direct elicitation of personal util...
A new method for valuing quality of life: Direct elicitation of personal util...A new method for valuing quality of life: Direct elicitation of personal util...
A new method for valuing quality of life: Direct elicitation of personal util...
 
Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...Using patient reported outcome measure in a cross-cultural context: conceptua...
Using patient reported outcome measure in a cross-cultural context: conceptua...
 
Can we really compare and aggregate PRO data between people and setting
Can we really compare and aggregate PRO data  between people and settingCan we really compare and aggregate PRO data  between people and setting
Can we really compare and aggregate PRO data between people and setting
 
Is balancing value demonstration for payers and patient interests a feasible ...
Is balancing value demonstration for payers and patient interests a feasible ...Is balancing value demonstration for payers and patient interests a feasible ...
Is balancing value demonstration for payers and patient interests a feasible ...
 
Modelling the Impact of Reform to the Cancer Drugs Fund
Modelling the Impact of Reform to the Cancer Drugs FundModelling the Impact of Reform to the Cancer Drugs Fund
Modelling the Impact of Reform to the Cancer Drugs Fund
 
The Distribution of the EQ-5D-5L Index in Patient Populations
The Distribution of the EQ-5D-5L Index in Patient PopulationsThe Distribution of the EQ-5D-5L Index in Patient Populations
The Distribution of the EQ-5D-5L Index in Patient Populations
 
Adrian Towse Presentation - Affordability
Adrian Towse Presentation - Affordability Adrian Towse Presentation - Affordability
Adrian Towse Presentation - Affordability
 
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated He...
 

Ähnlich wie ISPOR poster - direct elicitation 280415

This is my statistics exam I need help I have been lost this whole s.docx
This is my statistics exam I need help I have been lost this whole s.docxThis is my statistics exam I need help I have been lost this whole s.docx
This is my statistics exam I need help I have been lost this whole s.docx
divinapavey
 
WEEK 5 – EXERCISES Enter your answers in the spaces pr.docx
WEEK 5 – EXERCISES Enter your answers in the spaces pr.docxWEEK 5 – EXERCISES Enter your answers in the spaces pr.docx
WEEK 5 – EXERCISES Enter your answers in the spaces pr.docx
paynetawnya
 
Identify each of the following as examples of nominal, ordinal, inte.docx
Identify each of the following as examples of nominal, ordinal, inte.docxIdentify each of the following as examples of nominal, ordinal, inte.docx
Identify each of the following as examples of nominal, ordinal, inte.docx
scuttsginette
 
Parametric tests seminar
Parametric tests seminarParametric tests seminar
Parametric tests seminar
drdeepika87
 
1) You want to compare improvement in depression scores on the PHQ-9.docx
1) You want to compare improvement in depression scores on the PHQ-9.docx1) You want to compare improvement in depression scores on the PHQ-9.docx
1) You want to compare improvement in depression scores on the PHQ-9.docx
lindorffgarrik
 
The quiz has two portions Multiple Choice (8 problems, 32 p.docx
The quiz has two portions Multiple Choice (8 problems, 32 p.docxThe quiz has two portions Multiple Choice (8 problems, 32 p.docx
The quiz has two portions Multiple Choice (8 problems, 32 p.docx
helen23456789
 
Lecture 12 Chi-Square.pptx
Lecture 12 Chi-Square.pptxLecture 12 Chi-Square.pptx
Lecture 12 Chi-Square.pptx
shakirRahman10
 

Ähnlich wie ISPOR poster - direct elicitation 280415 (20)

ISoQOL poster - PUF 2015
ISoQOL poster - PUF 2015ISoQOL poster - PUF 2015
ISoQOL poster - PUF 2015
 
Chi-square test.pptx
Chi-square test.pptxChi-square test.pptx
Chi-square test.pptx
 
Cadth 2015 e3 eq5 d
Cadth 2015 e3  eq5 dCadth 2015 e3  eq5 d
Cadth 2015 e3 eq5 d
 
Repeated Measures t-test
Repeated Measures t-testRepeated Measures t-test
Repeated Measures t-test
 
Hypothesis testing for nonparametric data
Hypothesis testing for nonparametric data Hypothesis testing for nonparametric data
Hypothesis testing for nonparametric data
 
Inferential Statistics.pptx
Inferential Statistics.pptxInferential Statistics.pptx
Inferential Statistics.pptx
 
Chris and Andrew 20.4.2023.pptx
Chris and Andrew 20.4.2023.pptxChris and Andrew 20.4.2023.pptx
Chris and Andrew 20.4.2023.pptx
 
This is my statistics exam I need help I have been lost this whole s.docx
This is my statistics exam I need help I have been lost this whole s.docxThis is my statistics exam I need help I have been lost this whole s.docx
This is my statistics exam I need help I have been lost this whole s.docx
 
WEEK 5 – EXERCISES Enter your answers in the spaces pr.docx
WEEK 5 – EXERCISES Enter your answers in the spaces pr.docxWEEK 5 – EXERCISES Enter your answers in the spaces pr.docx
WEEK 5 – EXERCISES Enter your answers in the spaces pr.docx
 
Identify each of the following as examples of nominal, ordinal, inte.docx
Identify each of the following as examples of nominal, ordinal, inte.docxIdentify each of the following as examples of nominal, ordinal, inte.docx
Identify each of the following as examples of nominal, ordinal, inte.docx
 
Parametric tests seminar
Parametric tests seminarParametric tests seminar
Parametric tests seminar
 
1) You want to compare improvement in depression scores on the PHQ-9.docx
1) You want to compare improvement in depression scores on the PHQ-9.docx1) You want to compare improvement in depression scores on the PHQ-9.docx
1) You want to compare improvement in depression scores on the PHQ-9.docx
 
Test of significance in Statistics
Test of significance in StatisticsTest of significance in Statistics
Test of significance in Statistics
 
Test of significance
Test of significanceTest of significance
Test of significance
 
Chi square
Chi squareChi square
Chi square
 
DIFFERENTIAL SCALES... new.pdf
DIFFERENTIAL SCALES... new.pdfDIFFERENTIAL SCALES... new.pdf
DIFFERENTIAL SCALES... new.pdf
 
Chi square test final
Chi square test finalChi square test final
Chi square test final
 
The quiz has two portions Multiple Choice (8 problems, 32 p.docx
The quiz has two portions Multiple Choice (8 problems, 32 p.docxThe quiz has two portions Multiple Choice (8 problems, 32 p.docx
The quiz has two portions Multiple Choice (8 problems, 32 p.docx
 
t-test
t-test t-test
t-test
 
Lecture 12 Chi-Square.pptx
Lecture 12 Chi-Square.pptxLecture 12 Chi-Square.pptx
Lecture 12 Chi-Square.pptx
 

Mehr von Office of Health Economics

Mehr von Office of Health Economics (20)

Annual lecture
Annual lecture Annual lecture
Annual lecture
 
Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20 Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20
 
Towse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne finalTowse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne final
 
Towse cgd price transparency seminar
Towse cgd price transparency seminarTowse cgd price transparency seminar
Towse cgd price transparency seminar
 
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money is
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-MollaIspor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to people
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of life
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMR
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in England
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
 

Kürzlich hochgeladen

₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...
₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...
₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...
Diya Sharma
 
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
hyt3577
 

Kürzlich hochgeladen (20)

Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 48 (Gurgaon)
 
Lorenzo D'Emidio_Lavoro sullaNorth Korea .pptx
Lorenzo D'Emidio_Lavoro sullaNorth Korea .pptxLorenzo D'Emidio_Lavoro sullaNorth Korea .pptx
Lorenzo D'Emidio_Lavoro sullaNorth Korea .pptx
 
Busty Desi⚡Call Girls in Vasundhara Ghaziabad >༒8448380779 Escort Service
Busty Desi⚡Call Girls in Vasundhara Ghaziabad >༒8448380779 Escort ServiceBusty Desi⚡Call Girls in Vasundhara Ghaziabad >༒8448380779 Escort Service
Busty Desi⚡Call Girls in Vasundhara Ghaziabad >༒8448380779 Escort Service
 
₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...
₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...
₹5.5k {Cash Payment} Independent Greater Noida Call Girls In [Delhi INAYA] 🔝|...
 
BDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 143 Noida Escorts >༒8448380779 Escort Service
 
America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...
America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...
America Is the Target; Israel Is the Front Line _ Andy Blumenthal _ The Blogs...
 
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 46 (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 46 (Gurgaon)Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 46 (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Gurgaon Sector 46 (Gurgaon)
 
1971 war india pakistan bangladesh liberation.ppt
1971 war india pakistan bangladesh liberation.ppt1971 war india pakistan bangladesh liberation.ppt
1971 war india pakistan bangladesh liberation.ppt
 
Enjoy Night⚡Call Girls Rajokri Delhi >༒8448380779 Escort Service
Enjoy Night⚡Call Girls Rajokri Delhi >༒8448380779 Escort ServiceEnjoy Night⚡Call Girls Rajokri Delhi >༒8448380779 Escort Service
Enjoy Night⚡Call Girls Rajokri Delhi >༒8448380779 Escort Service
 
BDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Indirapuram Escorts >༒8448380779 Escort Service
 
BDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Greater Noida Escorts >༒8448380779 Escort Service
 
05052024_First India Newspaper Jaipur.pdf
05052024_First India Newspaper Jaipur.pdf05052024_First India Newspaper Jaipur.pdf
05052024_First India Newspaper Jaipur.pdf
 
KAHULUGAN AT KAHALAGAHAN NG GAWAING PANSIBIKO.pptx
KAHULUGAN AT KAHALAGAHAN NG GAWAING PANSIBIKO.pptxKAHULUGAN AT KAHALAGAHAN NG GAWAING PANSIBIKO.pptx
KAHULUGAN AT KAHALAGAHAN NG GAWAING PANSIBIKO.pptx
 
Embed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopko
Embed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopkoEmbed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopko
Embed-2 (1).pdfb[k[k[[k[kkkpkdpokkdpkopko
 
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
{Qatar{^🚀^(+971558539980**}})Abortion Pills for Sale in Dubai. .abu dhabi, sh...
 
Group_5_US-China Trade War to understand the trade
Group_5_US-China Trade War to understand the tradeGroup_5_US-China Trade War to understand the trade
Group_5_US-China Trade War to understand the trade
 
TDP As the Party of Hope For AP Youth Under N Chandrababu Naidu’s Leadership
TDP As the Party of Hope For AP Youth Under N Chandrababu Naidu’s LeadershipTDP As the Party of Hope For AP Youth Under N Chandrababu Naidu’s Leadership
TDP As the Party of Hope For AP Youth Under N Chandrababu Naidu’s Leadership
 
Busty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort Service
Busty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort ServiceBusty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort Service
Busty Desi⚡Call Girls in Sector 62 Noida Escorts >༒8448380779 Escort Service
 
06052024_First India Newspaper Jaipur.pdf
06052024_First India Newspaper Jaipur.pdf06052024_First India Newspaper Jaipur.pdf
06052024_First India Newspaper Jaipur.pdf
 
Enjoy Night ≽ 8448380779 ≼ Call Girls In Palam Vihar (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Palam Vihar (Gurgaon)Enjoy Night ≽ 8448380779 ≼ Call Girls In Palam Vihar (Gurgaon)
Enjoy Night ≽ 8448380779 ≼ Call Girls In Palam Vihar (Gurgaon)
 

ISPOR poster - direct elicitation 280415

  • 1. Directly eliciting personal utility functions: a new way to value health-related quality of life (Poster PRM156) Koonal Shah, Nancy Devlin (Office of Health Economics, UK) Brendan Mulhern (CHERE, University of Technology Sydney, Australia) Ben van Hout (ScHARR, University of Sheffield, UK) For further information, contact kshah@ohe.org BACKGROUND • The end product of EQ-5D valuation studies is an algorithm describing, on average, the utility decrements associated with each dimension and level of problems within the EQ-5D descriptive system • Standard methods for eliciting health state preference data (e.g. TTO, DCE) vary considerably in approach, but have in common an aim to ‘uncover’ these preferences by asking survey respondents to evaluate a sub-set of health states, and then using their responses to infer the relative importance of the specific dimensions and levels to them • An alternative (and novel) approach is to directly ask respondents about their own personal utility functions • Instead of inferring respondents’ utility functions from their responses to abstract choice tasks, we propose directly asking people about the relative importance of the health dimensions and levels, and the interactions between them This study was funded by the EuroQol Research Foundation. The views expressed do not necessarily reflect the views of the EuroQol Research Foundation. METHOD / KEY INNOVATIONS • Paper- and computer-based tasks administered via F2F interviews • Focus is on reflection and open discussion of responses • Based on premise that respondents are constructing their preferences • Some elements draw on swing weighting approach (MCDA literature) A. WARM-UP TASKS • Self-reported health using EQ-5D and EQ-VAS • Ranking exercise: ranking of level-free descriptions of the five EQ-5D dimensions B. DIMENSION WEIGHTING TASK • Five cards: each describes an improvement from extreme problems to no problems in one of the EQ-5D dimensions • 0 to 100 scale: 100 refers to the most important improvement in health and 0 refers to an improvement that respondent does not feel is important or valuable at all • Respondent assigns a rating of 100 to the improvement (card) that is most important or valuable to them • Respondent then rates the other improvements using the same scale and in relation to the most important improvement • Responses generate a set of dimension weights, which will be presented diagrammatically to respondents (Fig 1) C. LEVEL WEIGHTING TASK • Three cards (for each dimension): no improvement (from extreme problems); intermediate improvement (from extreme problems to moderate problems) and largest possible improvement (from extreme problems to no problems) • 0 to 100 scale: 100 refers to the largest possible improvement and 0 refer to no improvement • Respondent rates the intermediate improvement using the 0 to 100 scale • Rating of 50 implies that respondent considers the improvement from extreme problems to moderate problems to be about as important as the improvement from moderate problems to no problems – may not always be the case • Responses generate a set of level weights, which will be combined with the dimension weights and presented diagrammatically to respondents (Fig 2) – opportunity for respondents to reflect and amend their answers D. VALIDATION EXERCISE • The information collected in C and D will be validated using a series of pairwise choice tasks • Purpose of the exercise is to validate our understanding of the responses and to identify any potential inconsistencies E. POSITIONING OF DEAD • Position of dead will be estimated by asking respondents to complete simple trade-off tasks where the unit of trade is dimension-specific levels (as opposed to time or risk, as in TTO and standard gamble, respectively) • Example: start with following pairwise choice: (X) 11113 for 10 years followed by death vs. (Y) ‘die immediately’ • If respondent prefers X, then X is worsened: (X) 31113 for 10 years followed by death vs. (Y) ‘die immediately’ • Continue until respondent switches to preferring Y, at which point the approximate location of dead can be identified • Exact selection of health states presented in option X will follow directly from responses to dimension weighting task Fig 1. Output from B Fig 2. Output from B & C Diagrams will be used to check whether respondents agree with our interpretation of their responses; changes to earlier answers permitted F. EXAMINATION OF INTERACTIONS • Systematic approach will be used to examine interactions G. DEBRIEFING • Views about feasibility of the approach and suggestions for improving questionnaire will be sought from both respondents and interviewers CURRENT STATUS • Draft questionnaire has been developed • Accompanying computer-based tool is in development • Pilot interviews to be conducted in Q2 2015 using convenience samples in Australia, Netherlands, UK • Revised questionnaire will be tested in Q3/Q4 2015